HORIZON 2020 dedicated SME instrument

In 2015 Biovica received a Horizon 2020 SME-grant (Phase 2)

Over 600 small and medium-sized enterprises (SME) applied for Horizon SME 2020-grants in 2014. After thorough evaluation, less than 10% received project support.  Biovica was one, receiving 682,000 Euros. The grant supports clinical validation of the DiviTum assay in two high profile clinical studies in Europe.  The studies carried out under this grant are in their final stages, and we expect results to be published in the near future.

The support is targeted to bridge the gap between research and the market by helping innovative enterprises to develop technological breakthroughs into viable products with real commercial potential.

Reference: http://ec.europa.eu/programmes/horizon2020/en/area/smes

About Horizon 2020 – The EU Framework Program for Research and Innovation

Horizon 2020 is the biggest EU Research and Innovation program ever with nearly €80 billion of funding available over 7 years (2014 to 2020) – in addition to the private investment that this money will attract. It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market. The goal is to ensure Europe produces world-class science, removes barriers to innovation and makes it easier for the public and private sectors to work together in delivering innovation.

Link to Horizon 2020